Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
Reset 

PEP Health Announces Best US Hospitals for Oncology Patient Experience in 2024

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  PEP Health

Lexogen launches end-to-end solutions for FFPE Transcriptomics

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Lexogen GmbH

Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Laboratory Corporation of America Holdings (LabCorp)

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Bio-Techne Corporation

XpertDox Teams Up with Positive Results Billing to Launch XpertCoding, an AI-Powered Medical Coding Platform, Enhancing Operational Efficiency

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Ginkgo BioWorks

Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Ginkgo BioWorks

Capital Rx Earns Accreditation from the National Committee for Quality Assurance (NCQA)

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Capital Rx

Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

UCB Launches Make HStory, an Educational Campaign Offering Resources and Support for Those Living with Hidradenitis Suppurativa

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  UCB INC. (US) | UCB

Avulux Welcomes More Than 200 Eye Care Clinics Nationwide to its Authorized Provider Program for Migraine & Light Sensitivity Lenses

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  BioMarin Pharmaceutical Inc.

Virtue Recovery Offers Holistic Therapy Options for Enhanced Rehabilitation

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Nth Cycle Receives $7.2M 48C Tax Credit Allocation from U.S. Department of Energy for Groundbreaking Critical Metal Refining Facility in Fairfield, OH

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

New Ultrasound IV Training Program Earns First-Ever Seal of Approval from Infusion Nurses Society

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties

Read more ››
By: PR Newswire Association LLC. - 10 Apr 2024
Related companies:  Moleculin Biotech, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
to the top ↑